FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dentistry. The wound surface is covered with 2 gauze tampons for 5 minutes to be removed consistently thereafter and placed in 3 graduated glasses each containing 50 ml of the transforming solution. The tampons are kept in each graduated glass for 3 minutes and wrung out thoroughly when carried to the next glass. The contents of the graduated glasses are poured out in a flask, stirred thoroughly. Then its optical density v. optical density of calibration solution is measured at wavelength 540 nm in a measuring cell. The index R is calculated by formula: R = E1/E2, where R is the ratio of optical density of the analysed sample to optical density of the calibration solution, E1 is optical density of the analysed solution, unit of opt.dens., E2 is optical density of the calibration solution, unit of opt.dens. If the R is 2.2 or more, haemostatic therapy is estimated to be inefficient.
EFFECT: method provides higher estimation accuracy by elimination of subjective estimation to effect on the results, as well as due to ingestion of unknown amount of blood, method is easy to implement, does not require expensive equipment and reactants.
4 dwg, 1 tbl.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF REMOVING TEETH OF HEMOPHILIA PATIENTS | 0 |
|
SU1570726A1 |
METHOD OF DETERMINING ANAMNESTIC INDEX OF BLEEDING SICKNESS | 2009 |
|
RU2416365C1 |
METHOD FOR PREVENTION OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH VON WILLEBRAND DISEASE DURING IN VITRO FERTILIZATION | 2023 |
|
RU2816883C1 |
METHOD FOR PREVENTING PYO-INFLAMMATORY COMPLICATIONS IN CASES OF MANDIBLE FRACTURE | 1998 |
|
RU2138995C1 |
METHOD FOR ASSESSING RISK OF BLEEDING DURING AND AFTER DENTAL INTERVENTIONS IN PATIENTS TAKING ORAL ANTICOAGULANTS | 2023 |
|
RU2813439C1 |
METHOD OF AUTOTRANSPLANTATION OF TOOTH WITH PRESERVING ITS PULP VIABILITY | 2015 |
|
RU2605630C1 |
METHOD FOR EVALUATING REACTION OF BLOOD COAGULATION | 2013 |
|
RU2683933C2 |
METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
METHOD FOR VON WILLEBRAND DISEASE (SUBTYPE 2N) DIAGNOSTICS | 2017 |
|
RU2657794C1 |
METHOD OF TREATING PANCREATONECROSIS | 2012 |
|
RU2531448C2 |
Authors
Dates
2009-09-10—Published
2007-12-14—Filed